Remimazolam: An Updated Review of a New Sedative and Anaesthetic

References

• Chen W, Chen S, Huang Y. Induction and maintenance of procedural sedation in adults: focus on remimazolam injection. Expert Rev Clin Pharmacol. 2021;14(4):411–426. doi:10.1080/17512433.2021.1901575
   PubMed Web of Science ®Google Scholar
• Dominguini D, Steckert AV, Michels M, et al. The effects of anaesthetics and sedatives on brain inflammation. Neurosci Biobehav Rev. 2021;127:504–513. doi:10.1016/j.neubiorev.2021.05.009
   Web of Science ®Google Scholar
• Barr J, Donner A. Optimal intravenous dosing strategies for sedatives and analgesics in the intensive care unit. Crit Care Clin. 1995;11(4):827–847. doi:10.1016/S0749-0704(18)30041-1
   Web of Science ®Google Scholar
• Wesolowski AM, Zaccagnino MP, Malapero RJ, Kaye AD, Urman RD. Remimazolam: pharmacologic considerations and clinical role in anesthesiology. Pharmacotherapy. 2016;36(9):1021–1027. doi:10.1002/phar.1806
   PubMed Web of Science ®Google Scholar
• Mertens MJ, Olofsen E, Burm AG, Bovill JG, Vuyk J. Mixed-effects modeling of the influence of alfentanil on propofol pharmacokinetics. Anesthesiology. 2004;100(4):795–805. doi:10.1097/00000542-200404000-00008
   Web of Science ®Google Scholar
• Choi GJ, Kang H, Baek CW, Jung YH, Ko JS. Etomidate versus propofol sedation for electrical external cardioversion: a meta-analysis. Curr Med Res Opin. 2018;34(11):2023–2029. doi:10.1080/03007995.2018.1519501
   PubMed Web of Science ®Google Scholar
• Kim KN, Lee HJ, Kim SY, Kim JY. Combined use of dexmedetomidine and propofol in monitored anesthesia care: a randomized controlled study. BMC Anesthesiol. 2017;17(1):34. doi:10.1186/s12871-017-0311-9
   Web of Science ®Google Scholar
• Tanious MK, Beutler SS, Kaye AD, Urman RD. New hypnotic drug development and pharmacologic considerations for clinical anesthesia. Anesthesiol Clin. 2017;35(2):e95–e113. doi:10.1016/j.anclin.2017.01.017
   Google Scholar
• Goudra B, Gouda G, Mohinder P. Recent developments in drugs for gi endoscopy sedation. Dig Dis Sci. 2020;65(10):2781–2788. doi:10.1007/s10620-020-06044-5
   PubMed Web of Science ®Google Scholar
• Whizar V, Garnica C, Gastelum R. Remimazolam: a new ultra short acting benzodiazepine. J Anesth Critic Care. 2016;4:1.
   Google Scholar
• Rogers WK, McDowell TS. Remimazolam, a short-acting GABA(A) receptor agonist for intravenous sedation and/or anesthesia in day-case surgical and non-surgical procedures. IDrugs. 2010;13(12):929–937.
   Google Scholar
• PAION AG. PAION announces submission of the marketing authorization application for remimazolam in procedural sedation to the European Medicines Agency. PAION AG. Available from: https://www.paion.com/. Accessed Nov 20, 2019.
   Google Scholar
• Keam SJ. Remimazolam: first approval. Drugs. 2020;80(6):625–633. doi:10.1007/s40265-020-01299-8
   PubMed Web of Science ®Google Scholar
• PAION AG. Mundipharma receives market approval for Anerem® (remimazolam) in general anesthesia in Japan. PAION AG. Available from: https://www.paion.com/. Accessed Jan 23, 2020.
   Google Scholar
• Kilpatrick GJ. Remimazolam: non-clinical and clinical profile of a new sedative/anesthetic agent. Front Pharmacol. 2021;12:690875. doi:10.3389/fphar.2021.690875
   PubMed Web of Science ®Google Scholar
• Oka S, Satomi H, Sekino R, et al. Sedation outcomes for remimazolam, a new benzodiazepine. J Oral Sci. 2021;63(3):209–211. doi:10.2334/josnusd.21-0051
   Web of Science ®Google Scholar
• Antonik LJ, Goldwater DR, Kilpatrick GJ, Tilbrook GS, Borkett KM. A placebo- and midazolam-controlled phase I single ascending-dose study evaluating the safety, pharmacokinetics, and pharmacodynamics of remimazolam (CNS 7056): part I. safety, efficacy, and basic pharmacokinetics. Anesth Analg. 2012;115(2):274–283. doi:10.1213/ANE.0b013e31823f0c28
   PubMed Web of Science ®Google Scholar
• Goudra BG, Singh PM. Remimazolam: the future of its sedative potential. Saudi J Anaesth. 2014;8(3):388–391. doi:10.4103/1658-354X.136627
   PubMedGoogle Scholar
• Kilpatrick GJ, McIntyre MS, Cox RF, et al. CNS 7056: a novel ultra-short-acting benzodiazepine. Anesthesiology. 2007;107(1):60–66. doi:10.1097/01.anes.0000267503.85085.c0
   PubMed Web of Science ®Google Scholar
• Sneyd JR. Remimazolam: new beginnings or just a me-too? Anesth Analg. 2012;115(2):217–219. doi:10.1213/ANE.0b013e31823acb95
   PubMed Web of Science ®Google Scholar
• Freyer N, Knöspel F, Damm G, et al. Metabolism of remimazolam in primary human hepatocytes during continuous long-term infusion in a 3-D bioreactor system. Drug Des Devel Ther. 2019;13:1033–1047. doi:10.2147/DDDT.S186759
   PubMed Web of Science ®Google Scholar
• Wiltshire HR, Kilpatrick GJ, Tilbrook GS, Borkett KM. A placebo- and midazolam-controlled phase I single ascending-dose study evaluating the safety, pharmacokinetics, and pharmacodynamics of remimazolam (CNS 7056): part II. Population pharmacokinetic and pharmacodynamic modeling and simulation. Anesth Analg. 2012;115(2):284–296. doi:10.1213/ANE.0b013e318241f68a
   PubMed Web of Science ®Google Scholar
• Schüttler J, Eisenried A, Lerch M, Fechner J, Jeleazcov C, Ihmsen H. Pharmacokinetics and pharmacodynamics of remimazolam (CNS 7056) after continuous infusion in healthy male volunteers: part I. pharmacokinetics and clinical pharmacodynamics. Anesthesiology. 2020;132(4):636–651. doi:10.1097/ALN.0000000000003103
   PubMed Web of Science ®Google Scholar
• Upton RN, Somogyi AA, Martinez AM, Colvill J, Grant C. Pharmacokinetics and pharmacodynamics of the short-acting sedative CNS 7056 in sheep. Br J Anaesth. 2010;105(6):798–809. doi:10.1093/bja/aeq260
   PubMed Web of Science ®Google Scholar
• Deng Y, Qin Z, Wu Q, et al. Efficacy and safety of remimazolam besylate versus dexmedetomidine for sedation in non-intubated older patients with agitated delirium after orthopedic surgery: a randomized controlled trial. Drug Des Devel Ther. 2022;16:2439–2451. doi:10.2147/DDDT.S373772
   PubMed Web of Science ®Google Scholar
• Saari TI, Uusi-Oukari M, Ahonen J, Olkkola KT. Enhancement of GABAergic activity: neuropharmacological effects of benzodiazepines and therapeutic use in anesthesiology. Pharmacol Rev. 2011;63(1):243–267. doi:10.1124/pr.110.002717
   Web of Science ®Google Scholar
• Zhou Y, Hu P, Jiang J. Metabolite characterization of a novel sedative drug, remimazolam in human plasma and urine using ultra high-performance liquid chromatography coupled with synapt high-definition mass spectrometry. J Pharm Biomed Anal. 2017;137:78–83. doi:10.1016/j.jpba.2017.01.016
   Web of Science ®Google Scholar
• Liu T, Lai T, Chen J, et al. Effect of remimazolam induction on hemodynamics in patients undergoing valve replacement surgery: a randomized, double-blind, controlled trial. Pharmacol Res Perspect. 2021;9(5):e00851. doi:10.1002/prp2.851
   PubMed Web of Science ®Google Scholar
• Stöhr T, Colin PJ, Ossig J, et al. Pharmacokinetic properties of remimazolam in subjects with hepatic or renal impairment. Br J Anaesth. 2021;127(3):415–423. doi:10.1016/j.bja.2021.05.027
   PubMed Web of Science ®Google Scholar
• Lee A, Shirley M. Remimazolam: a review in procedural sedation. Drugs. 2021;81(10):1193–1201. doi:10.1007/s40265-021-01544-8
   PubMed Web of Science ®Google Scholar
• Lohmer LL, Schippers F, Petersen KU, Stoehr T, Schmith VD. Time-to-event modeling for remimazolam for the indication of induction and maintenance of general anesthesia. J Clin Pharmacol. 2020;60(4):505–514. doi:10.1002/jcph.1552
   PubMed Web of Science ®Google Scholar
• Sheng XY, Liang Y, Yang XY, et al. Safety, pharmacokinetic and pharmacodynamic properties of single ascending dose and continuous infusion of remimazolam besylate in healthy Chinese volunteers. Eur J Clin Pharmacol. 2020;76(3):383–391. doi:10.1007/s00228-019-02800-3
   PubMed Web of Science ®Google Scholar
• Iirola T, Ihmsen H, Laitio R, et al. Population pharmacokinetics of dexmedetomidine during long-term sedation in intensive care patients. Br J Anaesth. 2012;108(3):460–468. doi:10.1093/bja/aer441
   PubMed Web of Science ®Google Scholar
• Worthington MT, Antonik LJ, Goldwater DR, et al. A phase Ib, dose-finding study of multiple doses of remimazolam (CNS 7056) in volunteers undergoing colonoscopy. Anesth Analg. 2013;117(5):1093–1100. doi:10.1213/ANE.0b013e3182a705ae
   PubMed Web of Science ®Google Scholar
• Vicari JJ. Sedation in the ambulatory endoscopy center: optimizing safety, expectations and throughput. Gastrointest Endosc Clin N Am. 2016;26(3):539–552. doi:10.1016/j.giec.2016.02.005
   PubMedGoogle Scholar
• Moon SH, Kim HK, Myung DS, Yoon SM, Moon W. 진정내시경시환자의 감시및관련장비 [Patient monitoring and associated devices during endoscopic sedation]. Korean J Gastroenterol. 2017;69(1):64–67. Korean. doi:10.4166/kjg.2017.69.1.64
   Google Scholar
• Borkett KM, Riff DS, Schwartz HI, et al. A Phase IIa, randomized, double-blind study of remimazolam (CNS 7056) versus midazolam for sedation in upper gastrointestinal endoscopy. Anesth Analg. 2015;120(4):771–780. doi:10.1213/ANE.0000000000000548
   PubMed Web of Science ®Google Scholar
• Chen SH, Yuan TM, Zhang J, et al. Remimazolam tosilate in upper gastrointestinal endoscopy: a multicenter, randomized, non-inferiority, phase III trial. J Gastroenterol Hepatol. 2021;36(2):474–481. doi:10.1111/jgh.15188
   PubMed Web of Science ®Google Scholar
• Tan Y, Ouyang W, Tang Y, Fang N, Fang C, Quan C. Effect of remimazolam tosilate on early cognitive function in elderly patients undergoing upper gastrointestinal endoscopy. J Gastroenterol Hepatol. 2022;37(3):576–583. doi:10.1111/jgh.15761
   PubMed Web of Science ®Google Scholar
• Cao Y, Chi P, Zhou C, Lv W, Quan Z, Xue FS. Remimazolam tosilate sedation with adjuvant sufentanil in Chinese patients with liver cirrhosis undergoing gastroscopy: a randomized controlled study. Med Sci Monit. 2022;28:e936580. doi:10.12659/MSM.936580
   PubMed Web of Science ®Google Scholar
• Rex DK, Bhandari R, Desta T, et al. A phase III study evaluating the efficacy and safety of remimazolam (CNS 7056) compared with placebo and midazolam in patients undergoing colonoscopy. Gastrointest Endosc. 2018;88(3):427–437.e426. doi:10.1016/j.gie.2018.04.2351
   PubMed Web of Science ®Google Scholar
• Liu X, Ding B, Shi F, et al. The efficacy and safety of remimazolam tosilate versus etomidate-propofol in elderly outpatients undergoing colonoscopy: a prospective, randomized, single-blind, non-inferiority trial. Drug Des Devel Ther. 2021;15:4675–4685. doi:10.2147/DDDT.S339535
   PubMed Web of Science ®Google Scholar
• Rex DK, Bhandari R, Lorch DG, Meyers M, Schippers F, Bernstein D. Safety and efficacy of remimazolam in high risk colonoscopy: a randomized trial. Dig Liver Dis. 2021;53(1):94–101. doi:10.1016/j.dld.2020.10.039
   PubMedGoogle Scholar
• Yao Y, Guan J, Liu L, Fu B, Chen L, Zheng X. Discharge readiness after remimazolam versus propofol for colonoscopy: a randomised, double-blind trial. Eur J Anaesthesiol. 2022;39(12):911–917. doi:10.1097/EJA.0000000000001715
   Web of Science ®Google Scholar
• Pastis NJ, Yarmus LB, Schippers F, et al. Safety and efficacy of remimazolam compared with placebo and midazolam for moderate sedation during bronchoscopy. Chest. 2019;155(1):137–146. doi:10.1016/j.chest.2018.09.015
   PubMed Web of Science ®Google Scholar
• Jia Z, Ren LX, Fan YT, Tan ZM. 甲苯磺酸瑞马唑仑用于纤维支气管镜检查中深度镇静的有效剂量观察 [Observation of effective dosage of remimazolam tosilate used for moderate-to-deep sedation in fiberoptic bronchoscopy]. Zhonghua Yi Xue Za Zhi. 2021;101(11):813–816. Chinese. doi:10.3760/cma.j.cn112137-20200901-02524
   Google Scholar
• Chen X, Xin D, Xu G, Zhao J, Lv Q. The efficacy and safety of remimazolam tosilate versus dexmedetomidine in outpatients undergoing flexible bronchoscopy: a prospective, randomized, blind, non-inferiority trial. Front Pharmacol. 2022;13:902065. doi:10.3389/fphar.2022.902065
   PubMed Web of Science ®Google Scholar
• Masui K. Remimazolam besilate, a benzodiazepine, has been approved for general anesthesia!! J Anesth. 2020;34(4):479–482. doi:10.1007/s00540-020-02755-1
   Web of Science ®Google Scholar
• Doi M, Morita K, Takeda J, Sakamoto A, Yamakage M, Suzuki T. Efficacy and safety of remimazolam versus propofol for general anesthesia: a multicenter, single-blind, randomized, parallel-group, phase IIb/III trial. J Anesth. 2020;34(4):543–553. doi:10.1007/s00540-020-02788-6
   PubMed Web of Science ®Google Scholar
• Doi M, Hirata N, Suzuki T, Morisaki H, Morimatsu H, Sakamoto A. Safety and efficacy of remimazolam in induction and maintenance of general anesthesia in high-risk surgical patients (ASA Class III): results of a multicenter, randomized, double-blind, parallel-group comparative trial. J Anesth. 2020;34(4):491–501. doi:10.1007/s00540-020-02776-w
   PubMed Web of Science ®Google Scholar
• Chae D, Kim HC, Song Y, Choi YS, Han DW. Pharmacodynamic analysis of intravenous bolus remimazolam for loss of consciousness in patients undergoing general anaesthesia: a randomised, prospective, double-blind study. Br J Anaesth. 2022;129(1):49–57. doi:10.1016/j.bja.2022.02.040
   PubMed Web of Science ®Google Scholar
• Tang F, Yi JM, Gong HY, et al. Remimazolam benzenesulfonate anesthesia effectiveness in cardiac surgery patients under general anesthesia. World J Clin Cases. 2021;9(34):10595–10603. doi:10.12998/wjcc.v9.i34.10595
   Web of Science ®Google Scholar
• Wahler S Difference in vasopressor use and usage patterns in patients undergoing cardiac surgery with remimazolam vs propofol/sevoflurane for general anesthesia. Paper presented at: Anesthesiology. 2015.
   Google Scholar
• Furuta M, Ito H, Yamazaki M. Anaesthetic management using remimazolam in a patient with severe aortic stenosis: a case report. BMC Anesthesiol. 2021;21(1):202. doi:10.1186/s12871-021-01422-6
   Web of Science ®Google Scholar
• Shi F, Chen Y, Li H, Zhang Y, Zhao T. Efficacy and safety of remimazolam tosilate versus propofol for general anesthesia in cirrhotic patients undergoing endoscopic variceal ligation. Int J Gen Med. 2022;15:583–591. doi:10.2147/IJGM.S345390
   PubMed Web of Science ®Google Scholar
• Shimamoto Y, Sanuki M, Kurita S, Ueki M, Kuwahara Y, Matsumoto A. Factors affecting prolonged time to extubation in patients given remimazolam. PLoS One. 2022;17(5):e0268568. doi:10.1371/journal.pone.0268568
   PubMed Web of Science ®Google Scholar
• Paion UKL, Services OC, Simbec R; Creative Clinical Research Gmb H. Efficacy and safety of remimazolam (CNS7056) compared to propofol for intravenous anesthesia during elective surgery. Available from: https://clinicaltrials.gov/show/NCT03661489. Accessed July 28, 2022.
   Google Scholar
• Petkus H, Willer BL, Tobias JD. Remimazolam in a pediatric patient with a suspected family history of malignant hyperthermia. J Med Cases. 2022;13(8):386–390. doi:10.14740/jmc3977
   PubMedGoogle Scholar
• Horikoshi Y, Kuratani N, Tateno K, et al. Anesthetic management with remimazolam for a pediatric patient with Duchenne muscular dystrophy. Medicine. 2021;100(49):e28209. doi:10.1097/MD.0000000000028209
   PubMed Web of Science ®Google Scholar
• Kamata K, Asagi S, Shimoda Y, et al. Successful recording of direct cortical motor-evoked potential from a pediatric patient under remimazolam anesthesia: a case report. JA Clin Rep. 2022;8(1):66. doi:10.1186/s40981-022-00555-y
   Web of Science ®Google Scholar
• Yamadori Y, Yamagami Y, Matsumoto Y, et al. General anesthesia with remimazolam for a pediatric patient with MELAS and recurrent epilepsy: a case report. JA Clin Rep. 2022;8(1):75. doi:10.1186/s40981-022-00564-x
   PubMed Web of Science ®Google Scholar
• Liu H. Remimazolam reduces emergence delirium in preschool children undergoing laparoscopic surgery by sevoflurane anesthesia. Avaliable from: https://clinicaltrials.gov/ct2/show/NCT04621305?term=NCT04621305&draw=2&rank=1. Accessed September 28, 2022.
   Google Scholar
• Fox G, Walker JL. Investigation of remimazolam in children undergoing sedation for medical procedures; 2021. Available from: https://clinicaltrials.gov/ct2/show/NCT04851717?term=remimazolam&cond=Pediatric&draw=2&rank=1. Accessed September 28, 2022.
   Google Scholar
• Liu H, Cai Y. Intranasal remimazolam for premedication in pediatric patient. Available from: https://clinicaltrials.gov/ct2/show/NCT04720963?term=remimazolam&cond=Pediatric&draw=2&rank=2. Accessed September 28, 2022.
   Google Scholar
• Hua F, Fang Y. Effect of remimazolam vs sevoflurane anesthesia on incidence of emergence agitation and complications in children undergoing ophthalmic surgery. Available from: https://clinicaltrials.gov/ct2/show/NCT05527314?term=remimazolam&cond=Pediatric&draw=2&rank=3. Accessed September 28, 2022.
   Google Scholar
• Kitaura A, Kosumi R, Iwamoto T, Nakao S. Remimazolam anesthesia for transcatheter mitral valve repair in a patient with mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS) syndrome: a case report. JA Clin Rep. 2022;8(1):38. doi:10.1186/s40981-022-00528-1
   Web of Science ®Google Scholar
• Nishihara N, Tachibana S, Ikeshima M, Ino A, Yamakage M. Remimazolam enabled safe anesthetic management during tracheostomy in a patient with amyotrophic lateral sclerosis: a case report. JA Clin Rep. 2022;8(1):25. doi:10.1186/s40981-022-00514-7
   Web of Science ®Google Scholar
• Suzuki Y, Doi M, Nakajima Y. General anesthesia with remimazolam in a patient with mitochondrial encephalomyopathy: a case report. JA Clin Rep. 2021;7(1):51. doi:10.1186/s40981-021-00454-8
   Web of Science ®Google Scholar
• Zhang S, Wang J, Ran R, Peng Y, Xiao Y. Efficacy and safety of remimazolam tosylate in hysteroscopy: a randomized, single-blind, parallel controlled trial. J Clin Pharm Ther. 2022;47(1):55–60. doi:10.1111/jcpt.13525
   PubMed Web of Science ®Google Scholar
• Liu S, Su L, Zhang B, et al. The availability and safety study of remimazolam besylate for injection on sedation of ERAS Patients under mechanical ventilation in ICU: protocol for a randomized, open-label, controlled trial. Front Med. 2021;8:735473. doi:10.3389/fmed.2021.735473
   Web of Science ®Google Scholar
• Petersen KU Pre-clinical profile of Remimazolam and pharmacokinetics. 3rd annual meeting of the Japan society for clinical anesthesia.Tokyo, Japan; 2017.
   Google Scholar
• Zhou J, Leonowens C, Ivaturi VD, et al. Population pharmacokinetic/pharmacodynamic modeling for remimazolam in the induction and maintenance of general anesthesia in healthy subjects and in surgical subjects. J Clin Anesth. 2020;66:109899. doi:10.1016/j.jclinane.2020.109899
   PubMed Web of Science ®Google Scholar
• Io T, Saunders R, Pesic M, Petersen KU, Stoehr T. A miniature pig model of pharmacological tolerance to long-term sedation with the intravenous benzodiazepines; midazolam and remimazolam. Eur J Pharmacol. 2021;896:173886. doi:10.1016/j.ejphar.2021.173886
   Web of Science ®Google Scholar
• Choi HR, Song IA. Review of remimazolam and sedatives in the intensive care unit. Acute Crit Care. 2022;37(2):151–158. doi:10.4266/acc.2022.00619
   Web of Science ®Google Scholar
• Song X, Wang F, Dong R, Zhu K, Wang C. Efficacy and safety of remimazolam tosilate combined with esketamine for analgesic sedation in mechanically ventilated ICU patients: a single-arm clinical study protocol. Front Med. 2022;9:832105. doi:10.3389/fmed.2022.832105
   Web of Science ®Google Scholar
• Peking Union Medical College H, Yichang Humanwell Pharmaceutical Co L. The availability and safety study of remimazolam besylate for injection on sedation of ERAS patients. Available from: https://clinicaltrials.gov/show/NCT04947345. Accessed July 1, 2022.
   Google Scholar
• Tianjin Nankai H. Remimazolam for sedation in ICU patients undergoing mechanical ventilation. Available from: https://clinicaltrials.gov/show/NCT04815265. Accessed June 30, 2022.
   Google Scholar
• Xuan S. Remazolam toluenesulfonate combined with esketamine for the efficacy and safety of analgesic sedation in ICU patients on mechanical ventilation: a single arm trial clinical study protocol. Available from: http://www.chictr.org.cn/showproj.aspx?proj=136350. Accessed July 28, 2022.
   Google Scholar
• Guo J, Qian Y, Zhang X, Han S, Shi Q, Xu J. Remimazolam tosilate compared with propofol for gastrointestinal endoscopy in elderly patients: a prospective, randomized and controlled study. BMC Anesthesiol. 2022;22(1):180. doi:10.1186/s12871-022-01713-6
   Web of Science ®Google Scholar
• Chen S, Wang J, Xu X, et al. The efficacy and safety of remimazolam tosylate versus propofol in patients undergoing colonoscopy: a multicentered, randomized, positive-controlled, phase III clinical trial. Am J Transl Res. 2020;12(8):4594–4603.
   PubMed Web of Science ®Google Scholar
• Guan X, Jiao Z, Gong X, et al. Efficacy of pre-treatment with remimazolam on prevention of propofol-induced injection pain in patients undergoing abortion or curettage: a prospective, double-blinded, randomized and placebo-controlled clinical trial. Drug Des Devel Ther. 2021;15:4551–4558. doi:10.2147/DDDT.S334100
   Web of Science ®Google Scholar
• Hari Y, Satomi S, Murakami C, et al. Remimazolam decreased the incidence of early postoperative nausea and vomiting compared to desflurane after laparoscopic gynecological surgery. J Anesth. 2022;36(2):265–269. doi:10.1007/s00540-022-03041-y
   Web of Science ®Google Scholar
• Schippers F, Pesic M, Saunders R, et al. Randomized crossover trial to compare abuse liability of intravenous remimazolam versus intravenous midazolam and placebo in recreational central nervous system depressant users. J Clin Pharmacol. 2020;60(9):1189–1197. doi:10.1002/jcph.1614
   PubMed Web of Science ®Google Scholar
• Sasaki H, Hoshijima H, Mizuta K. Ringer’s acetate solution-induced precipitation of remimazolam. Br J Anaesth. 2021;126(3):e87–e89. doi:10.1016/j.bja.2020.11.021
   Web of Science ®Google Scholar
• Matsuo M, Okada K, Onuki Y, Yamazaki M. Incompatibility of remimazolam besylate with Ringer’s acetate infusion resulting in total occlusion of an intravenous catheter. BMJ Case Rep. 2021;14(4):e241622. doi:10.1136/bcr-2021-241622
   Google Scholar